Serous ovarian borderline tumors: modern classification and biology
- Authors: Davydova I.Y.1, Kuznetsov V.V1, Karseladze A.I1, Meshcheryakova L.A1
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center
- Issue: Vol 21, No 5 (2016)
- Pages: 228-232
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40285
- DOI: https://doi.org/10.18821/1028-9984-2016-21-5-228-232
- ID: 40285
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Irina Yu. Davydova
N.N. Blokhin Russian Cancer Research Center
Email: davydova06@mail.ru
MD, PhD, senior researcher of the Gynecological Department of the Research Institute of Clinical Oncology Moscow, 115478, Russian Federation
V. V Kuznetsov
N.N. Blokhin Russian Cancer Research CenterMoscow, 115478, Russian Federation
A. I Karseladze
N.N. Blokhin Russian Cancer Research CenterMoscow, 115478, Russian Federation
L. A Meshcheryakova
N.N. Blokhin Russian Cancer Research CenterMoscow, 115478, Russian Federation
References
- Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am. J. Clin. Pathol. 2005; 123 (Suppl.): 13-57.
- Taylor H.C. Jr. Malignant and semi malignant tumours of the ovary. Surg. Gynecol. 1929; 48: 204-30.
- Silverberg S. Borderline ovarian tumors: consensus, controversy, and continuing challenges. Pathol. Case Rev. 2006; 11: 9-17.
- Bast R.C. Jr., Hennessy B., Mills G.B. The biology of ovarian cancer: new opportunities for translation. Nat. Rev.Cancer. 2009; 9: 415-28.
- Cadron I., Leunen K., Van Gorp T., Amant F., Neven P., Vergote I. Management of borderline ovarian neoplasms. J. Clin. Oncol. 2007; 25: 2928-37.
- deSouza N.M., O’Neill R., McIndoe G.A., Dina R., Soutter W.P. Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease. Am. J. Roentgenol. 2005; 184: 999-1003.
- Gershenson D.M. Clinical management potential tumours of low malignancy. Best Pract. Res. Clin. Obstetr. Gynaecol. 2002; 16: 513-27.
- Swanton A., Bankhead C.R., Kehoe S. Pregnancy rates after conservative treatment for borderline ovarian tumours: a systematic review. Eur. J. Obstetr. Gynecol. Reprod. Biol. 2007; 135: 3-7.
- Gotlieb W.H., Chetrit A., Menczer J., Hirsh-Yechezkel G., Lubin F., Friedman E. et al. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol. Oncol. 2005; 97: 780-3.
- Webb P.M., Purdie D.M., Grover S., Jordan S., Dick M.L., Green A.C. Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer. Gynecol. Oncol. 2004; 92: 232-9.
- Kurman R.J., Сarcanqiu M.L., Herrington C.S., Young R.H. WHO Classification of Tumours of Female Reproductive Organs. 4-th Ed. - Lyon: IARS; 2014.
- Tavassoli F.A., Devilee P. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Lyon: IARC Press; 2003.
- Jones M.B. Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin. Obstetr. Gynecol. 2006; 49: 517-25.
- Kurman R.J., Shih Ie.M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int. J. Gynecol. Pathol. 2008; 27: 151-60.
- Shih Ie.M, Kurman R.J. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am. J. Pathol. 2004; 164: 1511-8.
- Shih Ie.M., Kurman R.J. Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin. Cancer Res. 2005; 11: 7273-9.
- Sieben N.L., Oosting J., Flanagan A.M., Prat J., Roemen G.M., Kolkman-Uljee S.M. et al. Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors. J. Clin. Oncol. 2005; 23: 7257-64.
- Bell D.A., Scully R.E. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum. Pathol. 1990; 21: 397-403.
- Fadare O. Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors). Int. J. Gynecol. Cancer. 2009; 19: 103-8.
- Seidman J.D., Kurman R.J. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum. Pathol. 2000; 31: 539-57.
- Longacre T.A., Kempson R.L., Hendrickson M.R. Well-differentiated serous neoplasms of the ovary. Pathology (Philad.). 1993; 1(2): 255-306.
- Leitao M.M. Jr., Boyd J., Hummer A., Olvera N., Arroyo C.D., Venkatraman E. et al Clinicopathologic analysis of early-stage sporadic ovarian carcinoma. Am. J. Surg. Pathol. 2004; 28(2): 147-59.
- Hogg R., Scurry J., Kim S.N., Friedlander M., Hacker N. Microinvasion links ovarian serous borderline tumor and grade 1 invasivecarcinoma. Gynecol. Oncol. 2007; 106(1): 44-51.
- Morice P., Camatte S., Rey A., Atallah D., Lhommé C., Pautier P. et al. Prognostic factors for patients with advanced stage serous borderline tumours ofthe ovary. Ann. Oncol. 2003; 14(4): 592-8.
- Silva E.G., Gershenson D.M., Malpica A., Deavers M. The recurrence and the overall survival rates of ovarian serous borderlineneoplasms with noninvasive implants is time dependent. Am. J. Surg. Pathol. 2006; 30(11): 1367-71.
- Katzenstein A.L., Mazur M.T., Morgan T.E., Kao M. Proliferative serous tumors of the ovary. Histologic features and prognosis. Am. J. Surg. Pathol. 1978; 2(4): 339-55.
- McKenney J.K., Balzer B.L., Longacre T.A. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion. Am. J. Surg. Pathol. 2006; 30(10): 1209-21.
- Mooney J., Silva E., Tornos C., Gershenson D. Unusual features of serous neoplasms of low malignant potential during pregnancy. Gynecol. Oncol. 1997; 65(1): 30-5.
- Kempson R.L., Hendrickson M.R. Ovarian serous borderline tumors: the citadel defended. Hum. Pathol. 2000; 31(5): 525-6.
- Scully R.E., Young R., Clement P.B. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube and Broad Ligament. In: Atlas of Tumor Pathology. 3rd Series. Washington DC: Arm Forces Institute of Pathology; 1998: Fascicle 23.
- Silva E.G., Kurman R.J., Russell P., Scully R.E. Symposium: ovarian tumors of borderline malignancy. Int. J. Gynecol. Pathol. 1996; 15(4): 281-302.
- Longacre T.A., McKenney J.K., Tazelaar H.D., Kempson R.L., Hendrickson M.R. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am. J. Surg. Pathol. 2005; 29(6): 707-23.
- Prat J., De Nictolis M. Serous borderline tumors of the ovary: a longterm follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am. J. Surg. Pathol. 2002; 26(9): 1111-28.
- Sangoi A., McKenney J.K., Dadras S.S., Longacre T.A. Lymphatic Vascyular Invaqsion in Ovarian Serous Tumors of Low Malignant Potential with Stromal Microinvasion. A case Study. Am. J. Surg. Pathol. 2008; 32(2): 261-8.
- Russell P. The pathological assessment of ovarian neoplasms. II: The proliferating ‘epithelial’ tumours. Pathology. 1979; 11(2): 251-82.
- Serov S.F., Scully S.R., Sobin L.H. Histologic Typing of Ovarian Tumors. Geneva: World Health Organization; 1973.
- Diaz-Padilla I., Malpica A.L., Minig L., Chiva L.M., Gershenson D.M., Gonzalez-Martin A. Ovarian low-grade serous carcinoma: a comprehensive update. Gynecol. Oncol. 2012; 126(2): 279-85.
- Burks R.T., Sherman M.E., Kurman R.J. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am. J. Surg. Pathol. 1996; 20(11): 1319-30.
- Singer G., Stöhr R., Cope L., Dehari R., Hartmann A., Cao D.F. et al. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. Am. J. Surg. Pathol. 2005; 29(2): 218-24.
- Boyd C., McCluggage W.G. Low-grade ovarian serous neoplasms (Low-grade serous carcinoma and serous borderline tumor) associated with high grade serous or undifferentiated carcinoma: Report of a series of cases of an unusual phenomenon. Am. J. Surg. Pathol. 2012; 36(3): 368-75.
- May T., Virtanen C., Sharma M., Milea A., Begley H., Rosen B., Murphy K.J. Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary. Gynecol. Oncol. 2010; 117(1): 9-17.
- O’Neill C.J., Deavers M.T., Malpica A. et al. An immunohistochemical comparison between low-grade and high-grade ovarian serous. Am. J. Surg. Pathol. 2005; 29(8):1034-41.